Travel Grant 2024 Japan, Innovation Talk October 8
| Reference number | |
| Coordinator | AAX Biotech AB |
| Funding from Vinnova | SEK 24 497 |
| Project duration | October 2024 - October 2024 |
| Status | Completed |
| Venture | Global cooperation 2024 |
Important results from the project
The goals for this trip were fulfilled. Japan is an important market for AAX Biotech, as our target customers are pharma and biotech companies. AAX Biotech’s CEO, Maria L. Knudsen, presented at the Sweden Japan Innovation Talk on October 8th, organized by Vinnova, together with Business Sweden and the Embassy of Sweden in Tokyo. This event was an excellent opportunity for AAX Biotech to interact with stakeholders as well as to showcase our unique technologies.
Expected long term effects
The event resulted in physical interactions and discussions with representatives from the life science industry in Japan, allowing us to build trusting long lasting relationships, which is vital for doing business in Japan. This will be beneficial as we expand our partnerships into the Japanese market.
Approach and implementation
Our CEO gave a presentation at the event and established important contacts in Japanese organizations. Following the trip, we will stay in touch with these contacts through email and hopefully follow up with web meetings and future visits to Japan, in order to continue discussions on potential partnerships.